CVA Family Office’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $509 | Buy |
+14
| New | +$509 | ﹤0.01% | 1230 |
|
|
2022
Q4 | – | Sell |
-50
| Closed | -$2K | – | 996 |
|
|
2022
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 814 |
|
|
2022
Q2 | $3K | Buy |
+50
| New | +$3K | ﹤0.01% | 806 |
|
|
2022
Q1 | – | Sell |
-10
| Closed | -$1K | – | 985 |
|
|
2021
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 885 |
|